CClinicalTrials.gg
CompletedNCT05239195DEVICEUpdated Aug 19, 2024Results posted

DirEct Versus VIdeo LaryngosCopE Trial

An interventional study of Video Laryngoscope and Direct Laryngoscope in Acute Respiratory Failure, sponsored by Vanderbilt University Medical Center. Completed at 12 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-19.

Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
1,420
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Clinicians perform rapid sequence induction, laryngoscopy, and tracheal intubation for more than 5 million critically ill adults as a part of clinical care each year in the United States. Failure to intubate the trachea on the first attempt occurs in more than 10% of all tracheal intubation procedures performed in the emergency department (ED) and intensive care unit (ICU). Improving clinicians rate of intubation on the first attempt could reduce the risk of serious procedural complications.

In current clinical practice, two classes of laryngoscopes are commonly used to help clinicians view the larynx while intubating the trachea: a video laryngoscope (equipped with a camera and a video screen) and a direct laryngoscope (not equipped with a camera or video screen). For nearly all laryngoscopy and intubation procedures performed in current clinical practice, clinicians use either a video or a direct laryngoscope. Prior research has shown that use of a video laryngoscope improves the operator's view of the larynx compared to a direct laryngoscope. Whether use of a video laryngoscope increases the likelihood of successful intubation on the first attempt remains uncertain. A better understanding of the comparative effectiveness of these two common, standard-of-care approaches to laryngoscopy and intubation could improve the care clinicians deliver and patient outcomes.

Read the detailed description

Clinicians frequently perform tracheal intubation of critically ill patients in the emergency department (ED) or intensive care unit (ICU). In 10-20% of emergency tracheal intubations, clinicians are unable to intubate the trachea on the first attempt, which increases the risk of peri-intubation complications. Successful laryngoscopy and tracheal intubation requires using a laryngoscope to [1] visualize the larynx and vocal cords and [2] create a pathway through which an endotracheal tube can be advanced through the oropharynx and larynx and into the trachea.

In current clinical practice, two classes of laryngoscopes are commonly used by clinicians to view the larynx while intubating the trachea: a video laryngoscope (equipped with a camera and a video screen) and a direct laryngoscope (not equipped with a camera or video screen). Clinicians use either a video laryngoscope or a direct laryngoscope as standard of care for every laryngoscopy and intubation procedure performed in current clinical practice.

Direct Laryngoscope: The Macintosh direct laryngoscope consists of a battery-containing handle and a blade with a light source. The operator achieves a direct line of sight -from the operator's eye through the mouth to the larynx and trachea - by using the laryngoscope blade to displace the tongue and elevate the epiglottis.

Video Laryngoscope: Video laryngoscopes consist of a fiberoptic camera and light source near the tip of the laryngoscope blade, which transmits images to a video screen. The position of the camera near the tip of the laryngoscope blade facilitates visualization of the larynx and trachea.

Use of a video laryngoscope and use of a direct laryngoscope are both common, standard-of-care approaches the clinicians use to perform tracheal intubation in the ED and ICU in current clinical care.

Currently, it is unknown whether use of a video laryngoscope or use of a direct laryngoscope has any effect on successful intubation on the first attempt or any other outcome. Some prior research has raised the hypothesis that using a video laryngoscope would increase clinicians' rate of successful intubation on the first attempt by facilitating the view of the larynx. Some prior research has raised the hypothesis that using a direct laryngoscope would increase clinicians' rate of successful intubation on the first attempt by facilitating a clear pathway for placement of the tube through the mouth into the trachea.

To date, 8 small single-center randomized trials and one 371-patient multicenter randomized clinical trial have been conducted under waiver of or alteration of informed consent to compare use of a video vs a direct laryngoscope in the setting of emergency tracheal intubation in the ED or ICU. Two of these trials provide the most direct preliminary data for this proposal. The "Facilitating EndotracheaL intubation by Laryngoscopy technique and apneic Oxygenation Within the ICU (FELLOW)" randomized clinical trial, conducted under waiver of informed consent, compared these two standard-of-care approaches during 150 emergency tracheal intubations at Vanderbilt University Medical Center, finding no difference in the rate of successful intubation on the first attempt between use of a video and use of a direct laryngoscope. The "McGrath Mac Videolaryngoscope Versus Macintosh Laryngoscope for Orotracheal Intubation in the Critical Care Unit (MACMAN)" randomized clinical trial among 371 critically ill adults found no difference between use of a video vs direct laryngoscope in the rate of successful intubation on the first attempt. However, a hypothesis-forming post-hoc exploratory analysis of peri-intubation complications suggested that use of a video laryngoscope may be associated with a higher rate of complications than direct laryngoscope (9.5% vs 2.8%, respectively, p=0.01). These trials were underpowered to rule out small but clinically significant differences in first pass success, and were limited to intubations performed by inexperienced trainees in one practice setting (intensive care units), but they demonstrated hypothesis-generating findings requiring validation in larger trials that reflect the full spectrum of settings, operator specialties, and operator experience levels in which emergency tracheal intubation is routinely performed.

Because of the imperative to optimize emergency tracheal intubation in clinical care, the common use of both video and direct laryngoscopes in current clinical practice, and the lack of definitive data from randomized trials to definitively inform whether use of a video laryngoscope or a direct laryngoscope effects the rate of successful intubation on the first attempt, examining whether one approach increases the odds of successful intubation on the first attempt represents an urgent research priority. To address this knowledge gap, the investigators propose to conduct a large, multicenter, randomized clinical trial comparing use of a video laryngoscope versus use of a direct laryngoscope with regard to successful intubation on the first attempt among critically ill adults undergoing tracheal intubation in the ED or ICU.

02

Conditions studied

  • Acute Respiratory Failure

Keywords

  • Critical Illness
  • Emergency Airway Management
  • Tracheal intubation
  • Video laryngoscope
  • Direct laryngoscope
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's enrollment of 1,420 is above the median of 55 across 1,043 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.

Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient is located in a participating unit.
  • Planned procedure is orotracheal intubation using a laryngoscope.
  • Planned operator is a clinician expected to routinely perform tracheal intubation in the participating unit.

Exclusion criteria

Exclusion Criteria:

  • Patient is known to be less than 18 years old.
  • Patient is known to be pregnant.
  • Patient is known to be a prisoner.
  • Immediate need for tracheal intubation precludes safe performance of study procedures.
  • Operator has determined that use of a video laryngoscope or use of a direct laryngoscope is required or contraindicated for the optimal care of the patient.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,420 participants (actual)

Study arms

  • Active comparator
    Video Laryngoscope Group

    For patients assigned to the video laryngoscope group, the operator will use a video laryngoscope on the first laryngoscopy attempt. A video laryngoscope will be defined as a laryngoscope with a camera and a video screen. Trial protocol will not dictate the brand of video laryngoscope.

    Other: Video Laryngoscope

  • Active comparator
    Direct Laryngoscope Group

    For patients assigned to the direct laryngoscope group, the operator will use a direct laryngoscope on the first laryngoscopy attempt. A direct laryngoscope will be defined as a laryngoscope without a camera or a video screen. Trial protocol will not dictate the brand of direct laryngoscope or the blade shape.

    Other: Direct Laryngoscope

Interventions

  • OtherVideo Laryngoscope

    Laryngoscope with a camera and a video screen

  • OtherDirect Laryngoscope

    Laryngoscope without a camera or a video screen

06

What researchers measure

Primary outcomes

  1. Number of Intubations With Successful Intubation on the First Attempt

    The primary outcome is defined as placement of an endotracheal tube in the trachea with a single insertion of a laryngoscope blade into the mouth and EITHER a single insertion of an endotracheal tube into the mouth OR a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube over the bougie into the mouth.

    Time frame: Duration of procedure (minutes)

Secondary outcomes

  1. Number of Participants With Severe Complications of Tracheal Intubation

    The secondary outcome is defined as the number of patients who experienced one or more of the following occurring between induction and 2 minutes after successful intubation: * Severe hypoxemia (lowest oxygen saturation measured by pulse oximetry \< 80%); * Severe hypotension (systolic blood pressure \< 65 mm Hg or new or increased vasopressor administration); * Cardiac arrest not resulting in death within 1 hour of intubation; or * Cardiac arrest resulting in death within 1 hour of induction

    Time frame: from induction to 2 minutes following tracheal intubation

Other outcomes

  1. Duration of Laryngoscopy and Tracheal Intubation

    The interval (in seconds) between the first insertion of a laryngoscope blade into the mouth and the final placement of an endotracheal tube or tracheostomy tube in the trachea.

    Time frame: Duration of procedure (minutes)

  2. Number of Laryngoscopy Attempts

    Time frame: Duration of procedure (minutes)

  3. Number of Attempts to Cannulate the Trachea With a Bougie or an Endotracheal Tube

    Time frame: Duration of procedure (minutes)

  4. Successful Intubation on the First Attempt Without a Severe Complication

    This outcome reports the number of participants that experienced successful intubation on the first attempt without experiencing complications, a composite of two independent outcomes: successful intubation on the first attempt (the primary outcome of the trial) and severe complication (the secondary outcome of the trial).

    Time frame: from induction to 2 minutes following tracheal intubation

  5. Reason for Failure to Intubate on the First Attempt

    Providers could give more than one reason for failure to intubate on the first attempt for each intubation (not mutually exclusive). In addition, data on the reason for failure to intubate on the first attempt was missing for 23 patients in the video laryngoscope group and 40 patients in the direct laryngoscope group. Reason for failure among those who did not meet the primary outcome (successful intubation on the first attempt): * Inadequate view of the larynx * Inability to intubate the trachea with an endotracheal tube * Inability to cannulate the trachea with a bougie * Attempt aborted due to change in patient condition (e.g., worsening hypoxemia, hypotension, bradycardia, vomiting, bleeding) * Technical failure of the laryngoscope (e.g., battery, light source, camera, screen) * Other * Not Reported

    Time frame: Duration of procedure (minutes)

  6. Operator-reported Aspiration

    Time frame: from induction to 2 minutes following tracheal intubation

  7. Esophageal Intubation

    Time frame: from induction to 2 minutes following tracheal intubation

  8. Injury to the Teeth

    Time frame: from induction to 2 minutes following tracheal intubation

  9. ICU-free Days in the First 28 Days

    Time frame: 28 days

  10. Ventilator Free Days in the First 28 Days

    Time frame: 28 days

  11. All-cause In-hospital Mortality

    Time frame: 28 days

07

Results

Posted Aug 19, 2024

Participant flow

Participant flow — Overall Study
MilestoneVideo Laryngoscope GroupDirect Laryngoscope Group
Started707713
Completed705712
Not completed21
Withdrew: After enrollment, discovered to be a person experiencing incarceration.21

Outcome measures

PrimaryNumber of Intubations With Successful Intubation on the First Attempt

The primary outcome is defined as placement of an endotracheal tube in the trachea with a single insertion of a laryngoscope blade into the mouth and EITHER a single insertion of an endotracheal tube into the mouth OR a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube over the bougie into the mouth.

Time frame:
Duration of procedure (minutes)
Reported as:
Count of participants · Participants
Number of Intubations With Successful Intubation on the First Attempt
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Number of Intubations With Successful Intubation on the First Attempt600504
SecondaryNumber of Participants With Severe Complications of Tracheal Intubation

The secondary outcome is defined as the number of patients who experienced one or more of the following occurring between induction and 2 minutes after successful intubation: * Severe hypoxemia (lowest oxygen saturation measured by pulse oximetry \< 80%); * Severe hypotension (systolic blood pressure \< 65 mm Hg or new or increased vasopressor administration); * Cardiac arrest not resulting in death within 1 hour of intubation; or * Cardiac arrest resulting in death within 1 hour of induction

Time frame:
from induction to 2 minutes following tracheal intubation
Reported as:
Count of participants · Participants
Number of Participants With Severe Complications of Tracheal Intubation
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Number of Participants With Severe Complications of Tracheal Intubation151149
Other pre-specifiedDuration of Laryngoscopy and Tracheal Intubation

The interval (in seconds) between the first insertion of a laryngoscope blade into the mouth and the final placement of an endotracheal tube or tracheostomy tube in the trachea.

Time frame:
Duration of procedure (minutes)
Reported as:
Median · Seconds
Duration of Laryngoscopy and Tracheal Intubation
SecondsVideo Laryngoscope GroupDirect Laryngoscope Group
Duration of Laryngoscopy and Tracheal Intubation38 (26 to 60)46 (30 to 83)
Other pre-specifiedNumber of Laryngoscopy Attempts
Time frame:
Duration of procedure (minutes)
Reported as:
Count of participants · Participants
Number of Laryngoscopy Attempts
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Number of times a laryngoscope entered the patient's mouth (reported by observer) - 1636546
Number of times a laryngoscope entered the patient's mouth (reported by observer) - 254127
Number of times a laryngoscope entered the patient's mouth (reported by observer) - 3+1433
Other pre-specifiedNumber of Attempts to Cannulate the Trachea With a Bougie or an Endotracheal Tube
Time frame:
Duration of procedure (minutes)
Reported as:
Number · number of events
Number of Attempts to Cannulate the Trachea With a Bougie or an Endotracheal Tube
number of eventsVideo Laryngoscope GroupDirect Laryngoscope Group
Endotracheal Tube - 1646620
Endotracheal Tube - 24366
Endotracheal Tube - 3+1519
Bougie - 0364330
Bougie - 1316317
Bougie - 21933
Bougie - 3+627
Other pre-specifiedSuccessful Intubation on the First Attempt Without a Severe Complication

This outcome reports the number of participants that experienced successful intubation on the first attempt without experiencing complications, a composite of two independent outcomes: successful intubation on the first attempt (the primary outcome of the trial) and severe complication (the secondary outcome of the trial).

Time frame:
from induction to 2 minutes following tracheal intubation
Reported as:
Count of participants · Participants
Successful Intubation on the First Attempt Without a Severe Complication
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Successful Intubation on the First Attempt Without a Severe Complication484420
Other pre-specifiedReason for Failure to Intubate on the First Attempt

Providers could give more than one reason for failure to intubate on the first attempt for each intubation (not mutually exclusive). In addition, data on the reason for failure to intubate on the first attempt was missing for 23 patients in the video laryngoscope group and 40 patients in the direct laryngoscope group. Reason for failure among those who did not meet the primary outcome (successful intubation on the first attempt): * Inadequate view of the larynx * Inability to intubate the trachea with an endotracheal tube * Inability to cannulate the trachea with a bougie * Attempt aborted due to change in patient condition (e.g., worsening hypoxemia, hypotension, bradycardia, vomiting, bleeding) * Technical failure of the laryngoscope (e.g., battery, light source, camera, screen) * Other * Not Reported

Time frame:
Duration of procedure (minutes)
Reported as:
Count of participants · Participants
Reason for Failure to Intubate on the First Attempt
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Inadequate view of the larynx26123
Inability to intubate the trachea with an endotracheal tube4432
Inability to cannulate the trachea with a bougie719
Attempt aborted due to change in patient condition214
Technical failure of the laryngoscope (e.g., battery, light source, camera, screen)24
Other1310
Not Reported2340
Other pre-specifiedOperator-reported Aspiration
Time frame:
from induction to 2 minutes following tracheal intubation
Reported as:
Count of participants · Participants
Operator-reported Aspiration
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Operator-reported Aspiration712
Other pre-specifiedEsophageal Intubation
Time frame:
from induction to 2 minutes following tracheal intubation
Reported as:
Count of participants · Participants
Esophageal Intubation
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Esophageal Intubation69
Other pre-specifiedInjury to the Teeth
Time frame:
from induction to 2 minutes following tracheal intubation
Reported as:
Count of participants · Participants
Injury to the Teeth
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
Injury to the Teeth32
Other pre-specifiedICU-free Days in the First 28 Days
Time frame:
28 days
Reported as:
Median · days
ICU-free Days in the First 28 Days
daysVideo Laryngoscope GroupDirect Laryngoscope Group
ICU-free Days in the First 28 Days20 (0 to 25)19 (0 to 24)
Other pre-specifiedVentilator Free Days in the First 28 Days
Time frame:
28 days
Reported as:
Median · days
Ventilator Free Days in the First 28 Days
daysVideo Laryngoscope GroupDirect Laryngoscope Group
Ventilator Free Days in the First 28 Days24 (0 to 26)23 (0 to 26)
Other pre-specifiedAll-cause In-hospital Mortality
Time frame:
28 days
Reported as:
Count of participants · Participants
All-cause In-hospital Mortality
ParticipantsVideo Laryngoscope GroupDirect Laryngoscope Group
All-cause In-hospital Mortality184191

Adverse events

Collected over 28 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Video Laryngoscope Group184/705 (26.1%)0/705 (0%)0/705 (0%)
Direct Laryngoscope Group191/712 (26.8%)0/712 (0%)0/712 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Video Laryngoscope GroupDirect Laryngoscope GroupTotal
Median54 (36 to 66)55 (39 to 67)55 (38 to 67)
Sex: Female, Male
Sex: Female, Male(Participants)Video Laryngoscope GroupDirect Laryngoscope GroupTotal
Female240258498
Male465454919
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Video Laryngoscope GroupDirect Laryngoscope GroupTotal
Race or ethnic group — Non-Hispanic White360346706
Race or ethnic group — Non-Hispanic Black166167333
Race or ethnic group — Hispanic10194195
Race or ethnic group — Other6184145
Race or ethnic group — Not reported172138
Region of Enrollment
Region of Enrollment(participants)Video Laryngoscope GroupDirect Laryngoscope GroupTotal
United States7057121417
08

Study locations

12 sites
  • UAB Hospital
    Birmingham, Alabama 35233, United States
  • University of Colorado Denver
    Aurora, Colorado 80045, United States
  • Denver Health Medical Center
    Denver, Colorado 80204, United States
  • Ochsner Medical Center | Ochsner Health System
    New Orleans, Louisiana 70112, United States
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
  • Hennepin County Medical Center
    Minneapolis, Minnesota 55415, United States
  • Duke University Medical Center
    Durham, North Carolina 27710, United States
  • Wake Forest Baptist Medical Center
    Winston-Salem, North Carolina 27157, United States
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
  • Brooke Army Medical Center
    Fort Sam Houston, Texas 78234, United States
  • Baylor Scott & White Health
    Temple, Texas 76508, United States
  • Harborview Medical Center
    Seattle, Washington 98104, United States
09

References and documents

Study documents

  • Study protocol · Sep 30, 2021
  • Statistical analysis plan · Nov 8, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Following publication, individual patient data will be made available for sharing to researchers with 1) a signed data access agreement, 2) research testing a hypothesis, 3) a protocol that has been approved by an institutional review board, and 4) a proposal that has received approval from the principal investigator.

Supporting information: Study protocol, Sap

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05239195
Lead sponsor
Vanderbilt University Medical Center
Collaborators
University of Colorado, Denver
Responsible party
Jonathan Casey (Assistant Professor, Vanderbilt University Medical Center) — Principal investigator
First posted
Feb 14, 2022
Start date
Mar 19, 2022
Primary completion
Nov 17, 2022
Completion
Dec 16, 2022
Results posted
Aug 19, 2024
Last update
Aug 19, 2024

Study contacts

Matthew W Semler, MD, MSc
principal investigator · Vanderbilt University Medical Center
Adit A Ginde, MD, MPH
principal investigator · University of Colorado, Denver
Matthew E Prekker, MD, MPH
study chair · Hennepin County Medical Center, Minneapolis
Stacy A Trent, MD, MPH
study chair · Denver Health Medical Center
Brian E Driver, MD
study chair · Hennepin County Medical Center, Minneapolis
Jonathan D Casey, MD, MSc
study director · Vanderbilt University Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion